Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SynAct Pharma Major Shareholding Notification 2023

Jun 19, 2023

3114_iss_2023-06-19_2d770c97-a678-4da2-b7ca-58b24bd31e3e.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer SynAct Pharma AB

Holder

Thomas Jonassen

Instrument

Instrument Ordinary SE0008241491
Before the transaction
Shares 4,923,421
Voting rights 4,923,421
Transaction
Reason for major shareholding notification Sell
Date 16/06/2023
Limit for number of shares 15 %
Limit for number of votes 15 %
After the transaction
Quantity
Shares 4,693,421
Directly held voting rights 0
Indirectly held voting rights 4,693,421
Percentage
Directly held shares 14.74946 %
Directly held voting rights 0 %
Indirectly held voting rights 14.74946 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares
14.74946 % 4,693,421
paragraph, line 2 Instruments - FITA Ch. 4, section 2, first
first paragraph, line 3 Instruments - FITA Ch. 4, section 2,
- Physically settled
- Cash settled
Total 14.74946 % 4,693,421
Chain
of
controlling companies
Voting rights % Voting rights Company
11.09848 11.09848 Bioinvest ApS
3.65098 3.65098 Goodwind Holding GmbH
Group
total
holdings
Voting rights 14.74946
Percentage of voting rights 14.74946
Published
19/06/2023 16:17

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25